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Interaction of lymphotoxin a1b2 (LTa1b2) with its receptor is key for the generation and
maintenance of secondary lymphoid organ microstructure. We used mice conditionally
deficient for LTb on different lymphocyte subsets to determine how the LTb-dependent
lymphoid structure influences immune reactivity. All conditionally LTb-deficient mice
mounted normal immune responses against vesicular stomatitis virus (VSV), and were
protected against lymphocytic choriomeningitis virus (LCMV). In contrast, they
exhibited reduced immune responses against non-replicating antigens. Completely LTb-
deficient mice failed to retain VSV in the marginal zone and died from VSV infections,
and they became virus carriers following infection with the non-cytopathic LCMV,
which was correlated with defective virus replication in dendritic cells. It was ruled out
that LTb expression on lymphocytes influenced their activation, homing capacity, or
maturation. We therefore conclude that LTbexpression influences immune reactivity at
two distinct levels: (i) Expression of LTb on lymphocytes enhances the induction of
immune responses against limiting amounts of antigen. (ii) Expression of LTb on non-
lymphocytes governs antiviral immunity by enhancing antigen presentation on antigen-
presenting cells. This prevents cytotoxic T lymphocytes exhaustion or death of the host
by uncontrolled virus spread.
Introduction
The lymphotoxin (LT) signaling system plays an
important role in lymphoid organogenesis [1]. Produc-
tion of LTa1b2 is crucial for the formation of secondary
lymphoid organ anlagen [2–4] and the expression of
homeostatic chemokines [5]. Thus, LTa–/– mice [6, 7],
LTb–/– mice [8, 9] and mice deficient for the LTb
receptor (LTbR–/–, [10]), lack Peyer's patches (PP) and
most lymph nodes, and showmorphological deficiencies
of the spleen. Various attempts have been undertaken to
determine both the source and the targets of LTa1b2 in
lymphoid organogenesis as well as its time window of
action. CD4+CD3–IL-7R+ lymphoid tissue-inducing cells
(LTIC) have been shown to express LTa1b2 early during
ontogeny of lymph nodes [3] and PP [11]. Later, during
lymphoid organ development, B cells and T cells appear
to be the primary source [12, 13]. The target cells for
LTa1b2 are, in most instances, stromal cells of mesench-
ymal origin [4], which can differentiate into T or B cell
zone stromal cells.
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The structure of secondary lymphoid organs plays a
role in determining the capacity of an organism to
respond to antigens [14]. For example, LTb–/– mice and
LTa–/– mice, which display severe defects in lymphoid
organ structure, are known to be highly susceptible to
virus infections [15–17]. In contrast, mice with weaker
structural alterations, e.g. of the T cell zone in mice
deficient for CCR7 or its ligands [18, 19], or the B cell
zone in mice deficient for CXCR5 [20], show only a
minor impairment of antiviral immune responses.
Therefore, these studies do not establish which degree
of lymphoid organization is sufficient and which
lymphoid microcompartments are necessary for the
generation of antiviral immunity. As LTa1b2 is the key
inducer of lymphoid anlagen and constitutive chemo-
kines, mice conditionally deficient for LTb on distinct
lymphocyte subsets permit the analysis of graded defects
of lymphoid microarchitecture in the generation of
adaptive immune responses. Here, we used mice with
conditional inactivation of the LTb gene in T cells
(T-LTb–/–), B cells (B-LTb–/–), T and B cells (TB-LTb–/–)
or complete LTb–/– mice to determine how LTb from
T cells, B cells or non-T/non-B cells (e.g. NK cells, DC or
LTIC) provides the morphological basis for immune
reactivity against viruses and non-replicating antigens.
In contrast to LTb–/– mice, all cell-specifically LT-
deficient mice were able to mount protective antiviral
immune responses against viruses. However, none of
these strains were able to respond to non-replicating
antigens. In LTb–/– mice we found that virus could
spread in an uncontrolled fashion, due to incomplete
antigen retention in the spleen. These results suggest
that LTb regulates immunity at two levels: Expression of
LTb on T or B lymphocytes is crucial for the induction of
adaptive immune responses against small amounts of
antigen but dispensable for the induction of adaptive
responses against replicating infectious agents. Expres-
sion of LTbon cells other than Tand B cells (i.e. NK cells,
DC or LTIC) is key for antigen sampling by APC of the
marginal zone (MZ) and by DC.
Results
Defective architecture but normal cellularity of
secondary lymphoid organs in conditionally LTb-
deficient mice
Since LTa1b2 plays an important role in the formation
andmaintenance of secondary lymphoid organs, we first
characterized the structure of spleens and lymph nodes
of LTb-deficient mice. Mesenteric, inguinal, brachial,
para-aortal, submandibular, mediastinal and popliteal
lymph nodes and PP were present in C57BL/6, T-LTb–/–,
B-LTb–/– and TB-LTb–/–, but not in LTb–/– mice, which
only exhibited one small, poorly segmented mesenteric
lymph node (MLN) in 75% of the mice and no PP.
Immunohistochemistry on spleen sections of these
strains (Fig. 1A) revealed that T-LTb–/– mice showed a
largely intact splenic morphology, with the exception of
looser follicular dendritic cell (FDC) networks, as shown
by FDC-M1 staining. B-LTb–/– mice had normal B and
T cell zones, a rudimentary MZ and small, but still
detectable FDC-M1+ networks. TB-LTb–/– mice lacked
clearly demarcated Tand B cell zones, but also organized
MZ or FDC-M1+ networks. Networks of FDC within
PNA-positive GC could not even be induced inTB-LTb–/–,
or augmented in B-LTb–/–, following immunization of
these mice with the potent B and T helper cell-activating
antigen vesicular stomatitis virus (VSV) (Fig. 1B). LTb–/–
mice exhibited a weak segregation of T and B cell zones,
and the MZ and FDC networks were totally absent [21].
It is of note that these mice died between days 8 and 11
following VSV infection (see below).
With regard to the microanatomy of MLN (Fig. 2),
T-LTb–/– mice did not exhibit obvious morphological
defects. The only defect of B-LTb–/– and TB-LTb–/– mice
was an impairment of FDC-M1+ clusters. LTb–/– mice
additionally lacked MOMA-1+ cells of the subcapsular
sinus, and had no clearly segregated T and B cell zones.
We next enumerated the cellular constituents of
spleen, blood, inguinal lymph nodes and MLN of these
animals by FACS (Fig. 3 and data not shown). Blood was
of normal cellularity and lymph nodes and spleen were
of normal size in all mice, except in LTb–/– mice, which
lacked all lymph nodes except theMLN and had elevated
numbers of leukocytes in peripheral blood. In addition,
the cellular composition of spleen, lymph nodes and
blood was most profoundly altered in LTb–/– mice. As
expected, NK cells were almost undetectable in these
mice [22]. LTb-deficient DC precursors of the bone
marrow can differentiate normally [23], but
CD11c+CD11b+ myeloid DC show a homing defect to
spleens of LTb–/– mice [24]. This was mirrored by
increased numbers of DC in the blood of LTb–/– mice.
Mice that lacked LTb on T cells, i.e. the T-LTb–/– and
TB-LTb–/– strains showed slightly reduced numbers of
CD4+ and CD8+ T cells in blood and secondary
lymphoid organs, compared to B-LTb–/–. This may
reflect the reduced export of mature T cells from the
thymus in the absence of LTb-signaling [25]. In LTb–/–
mice this effect was likely masked by the general
lymphocytosis.
In summary, lymph nodes and spleen of T-, B-, and
TB-LTb–/– mice were relatively normal in terms of
overall cell numbers. Minor alterations of the cellular
composition of these organs and graded anomalies of
lymphoid structure were detected. Morphological de-
fects in LTb–/– mice, however, were more severe in that
they lacked most lymph nodes, PP, MOMA+ metallo-
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philic macrophages and ERTR9+macrophages of theMZ
(data not shown), and NK cells. Overall, the defects of
lymphoid organ microanatomy of these mouse strains
increased in severity as follows: C57BL/6 < T-LTb–/–
< B-LTb–/– < TB-LTb–/– < LTb–/– (see also [13]).
Correlation of LTb expression in secondary
lymphoid organs with integrity of lymphoid
microstructure
Next, we determined whether the severity of morpho-
logical defects within secondary lymphoid organs
correlated with the level of LTb expression. To this
end, we quantified LTb mRNA in spleens and MLN of
naive C57BL/6 mice, T-, B-, TB- and complete LTb–/–
mice by real-time RT-PCR (Fig. 4A). The morphological
defects correlated with reduced expression levels of LTb.
It is thus likely that the aberrant microstructure of
secondary lymphoid organs in these gene-targeted
strains was due to a dose effect of LTb during ontogeny.
Interestingly, less than 1% of the wild-type expression
level still allowed the formation of all lymph node
anlagen in TB-LTb–/– mice, whereas complete absence of
LTb expression in LTb–/– mice precluded the develop-
ment of most lymph nodes. This difference in lymph
node differentiation between TB-LTb–/– and LTb–/– mice
was striking and may reflect the expression of LTb on
LTIC of TB-LTb–/– but not of LTb–/– mice. Alternatively, it
may point out to a role of LTb derived from another non-
T non-B cell lineage in the formation of lymph node
anlagen. In line with this notion, we have found LTb
expression on NK cells and DC sorted from naive mice,
but only weak expression on macrophages (Fig. 4B). NK
cells, DC and macrophages expressed very low levels of
LTa, whereas macrophages showed strong expression of
TNF. LIGHT expression on most sorted cell types was
absent, except on T cells and DC, where it was close to
the level of detection (data not shown). To exclude locus
control or secondary effects due to deregulation of LTbR
or its ligands on mRNA expression levels, we analyzed
expression levels of LTa, TNF or herpes virus entry
mediator ligand (LIGHT) in spleens and MLN of LTb–/–,
B-LTb–/–, T-LTb–/– and T/B-LTb–/– mice and C57BL/6
controls by real-time RT-PCR. Consistent with a previous
report [21], we were not able to detect altered mRNA
expression levels of LTa, TNF and LIGHT in spleens or
Fig. 1. Immunohistochemistry of spleens of
LT-deficient mouse strains. (A) Immunohis-
tochemistry of naive spleens. Arrowheads
indicate the rudiment of the MZ in TB-LTb–/–
mice. (B) Immunohistochemistry of spleens
on day 14 following infection with 2 
106 PFU VSV-IND i.v. Markers and mouse
strains are indicated. Arrowheads indicate
FDC in B-LTb–/– mice. Original magnification
for all panels was 120x.
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MLN of LTb-deficient mouse strains when compared to
age-matched C57BL/6 controls, as indicated by not
significantly changed DDct levels (<2; data not shown).
The unique exception to the rule of unaltered expression
levels of other gene products from the TNF/LT locus in
LTb-deficient mice were spleens of complete LTb–/– mice
where we found a slight increase of LTa, but not TNF or
LIGHT expression.
Normal intrinsic T and B cell function in the
absence of LTb
Expression of LTa1b can be induced on the surface of
activated T and B cells [26], possibly secondary to the
activation-dependent induction of LTa [27]. Before
studying immune responses in LTb-deficient mice, we
therefore wanted to exclude that deficient LTb expres-
Fig. 3.Absolute cell counts of spleens, inguinal lymphnodes and blood of naive LTb-deficientmouse strains. Spleens, both inguinal
LN, or 100 lL of blood fromnaiveC57BL/6 or LTb-deficientmicewere analyzed for the givenmarkers by FACS. Bars representmeans
 SD of n = 3–7 mice.
Fig. 2. Immunohistochemistry ofMLNof
LTb-deficient mouse strains. Immuno-
histochemistry of MLN from naivemice.
Markers and mouse strains are indi-
cated. Original magnification was 120x.
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sion influenced the costimulatory, proliferative, migra-
tory or secretory activity of activated T and B cells. To
this end, we stimulated MACS-purified CD43– B cells for
3 days with anti-CD40 or LPS, and cytokines. LTb-
deficient B cells secreted IgM within normal levels
(Fig. 5A) and expressed normal levels of CD80 and CD86
(Fig. 5B, upper and middle panel). The proliferative
capacity of LTb–/– B cells was comparable to wild-type
controls as assessed by CFSE proliferation assays
(Fig. 5B, bottom panel). After 5 days of culture,
LTb–/– B cells had switched their immunoglobulin
isotype as efficiently as wild-type controls (Fig. 5C).
Next, we stimulated sorted CD4+ and CD8+ T cells of
C57BL/6 mice or LTb–/– mice in vitro, on plate-bound
anti-CD3 in the presence of anti-CD28 and IL-2.
Compared to C57BL/6 mice, neither CD4+ nor CD8+
T cells from LTb–/– mice showed differences in the
expression of activation markers (Fig. 5D) in their
cytokine secretion pattern (Fig. 5E) and in their
proliferative capacity (Fig. 5F). Finally, we compared
the capacity of T and B lymphocytes from LTb–/– versus
C57BL/6mice to home within a correctly formed splenic
microenvironment. For this purpose, 3  106 MACS-
sorted and CFSE-labeled Tor B lymphocytes from LTb–/–
or C57BL/6 mice were adoptively transferred to naive
C57BL/6 mice. When the spleens of these mice were
examined 6 h later, we observed a similar capacity of
LTb–/– T cells to enter the T cell zones (Fig. 5G, upper
row). Six hours after transfer, most LTb–/– and C57BL/6
B cells had entered B cell zones, while others were still
detected in the red pulp (Fig. 5G, lower row). Overall,
we conclude that LTb-deficiency does not confer an
intrinsic defect on lymphocyte activation, proliferation
or migration to the T or B cell zones.
We additionally tested whether LTb deficiency
affected lymphocyte development. B cell development
takes place in the BM, with the various developmental
stages expressing distinct markers. The BM of LTb–/–
mice was fractionated into subpopulations A–F by
cytofluorimetry according to the classification by Hardy
[28]. LTb–/– mice had normal frequencies of B cell
precursors, when compared to C57BL/6 bone marrow
(Fig. 6A, see legend for details). In addition, transitional
andmature B cells were present in normal frequencies in
spleens of LTb–/– mice (Fig. 6B). Thymi of LTb–/– mice
had a normal cellular composition when compared to
C57BL/6 mice, with only a mild elevation of single-
positive cells (Fig. 6C). Therefore, LTb–/– deficiency did
not cause an obvious developmental defect of T and
B lymphocytes.
Deficient B cell responses in LT-deficient mice at
low antigen doses
As shown above, LTb-deficiency did not cause obvious
defects in lymphocyte development or function at the
single-cell level. The series of conditionally LTb-targeted
mice therefore permitted investigations of the role of
stepwise reduced integrity of secondary lymphoid organ
structure on antiviral immunity.
All LTb-deficient mouse strains mounted early and
strong virus neutralizing IgM titers following infection
with 2  106 PFU of VSV (Fig. 7A). Surprisingly, LTb–/–
mice died between days 8 and 11 following infection
whilst all other LTb-deficient mice mounted comparable
viral neutralizing IgG titers, in spite of their compro-
Fig. 4. Expression levels of LTb mRNA in spleens, MLN and
sorted cell populations. (A) SYBR-greenTM based real-time RT-
PCRwith LTbexpression levels of C57BL/6mice set as 100% (n =
2 mice per group, PCR-reaction run in quadruplicates).
Numbers represent means of LTb expression in TB-LTb–/– mice
in percent. (B) SYBR-greenTM based real-time RT-PCR of sorted
cell populations from B6 mice with LTb, LTaor TNF expression
levels of B cells set as 100% (PCR run in triplicates).
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mised lymphoid microstructure (Fig. 7B). As shown in
Fig. 1B, VSV infection induced PNA-positive GC that
were partially or completely devoid of FDC, in B-LTb–/–
and TB-LTb–/– mice. It is thus possible that the
maturation of virus-neutralizing IgG was impaired in
these mice. Immunization with non-replicating UV-
inactivated VSV virions (UV-VSV), or recombinant VSV-
G, led to reduced IgM and IgG titers in all LTb-deficient
strains (Fig. 7A, B). These data indicated that a highly
organized lymphoid architecture was dispensable for
the generation of strong neutralizing antibody responses
against live VSV. However, a high degree of lymphoid
organization was necessary for the induction of
T-independent and T-dependent B cell responses against
non-replicating antigens such as UV-VSV or VSV-G.
Fig.5.Normal intrinsicBandTcell reactivityandmigrationinthe
absence of LTb. (A) IgM ELISA of supernatants of B cell cultures
fromLTb–/– (-/-)andC57BL/6 (+/+)miceonday 3 in thepresenceof
LPS or anti-CD40 plus IL-4 or IFN-c. Pooled cells of four spleens
were analyzed in duplicate wells, mean values are depicted. (B)
Comparable induction of costimulatory markers and compar-
able proliferation of purified B cells of C57BL/6 mice (left) and
LTb–/– mice (right). B cells were analyzed following three days of
culture in thepresenceof LPSand IL-4 (bold line) or LPSand IFN-c
(dashed line). Alternatively, B cellswere CFSE-labeled and loss of
the label was followed at day 3 (bottom panel); (C) Comparable
amountsofswitched immunoglobulin isotypescanbe induced in
vitro by purified LTb–/– and C57BL/6 B cells in the presence of
polarizingcytokines. IgG1and IgG2bELISAofday 5 supernatants
of in vitro cultured CD43– splenic B cells in the presence of anti-
CD40and IL-4or IFN-c. Pooledcells of four spleenswereanalyzed
in duplicate wells, mean values are depicted; (D) Purified CD4+
and CD8+ T cells of LTb–/– mice and C57BL/6 mice show
comparable expression of activation markers upon in vitro
stimulation. CD4+ or CD8+ T cells from C57BL/6 (shade) or LTb–/–
spleens (line) were stimulated for 5 days in vitro. Results of one
out of two similar experiments are shown. (E) Purified CD4+ and
CD8+ T cells from C57BL/6 mice (left) and LTb–/– mice (right)
expressaTh1/Tc1-likepatternofcytokinesupon3 daysof in vitro
stimulation. The dot plots shown are representative of two
similar experiments. (F) Purified CD4+ and CD8+ T cells from
LTb–/– mice and C57BL/6 mice show comparable proliferative
capacity.CFSE-labeledCD4+orCD8+cells fromC57BL/6 (shade)or
LTb–/– spleens (line) were stimulated for 3 days in vitro, and
loss of the label was analyzed. Results of one out of two
similar experiments are shown. (G) Similar capacity of LTb–/– and
C57BL/6 splenocytes to enter intact secondary lymphoid organs.
Thy.1.2+ or B220+ cells from LTb–/– and C57BL/6 mice were CFSE-
labeled and adoptively transferred to naive C57BL/6 mice.
Spleens were stained with anti-CD4-APC, anti-B220-biotin,
SA-TRITC and DAPI and analyzed by fluorescence microscopy
(original magnification was 120).
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Reduced capture of VSV particles in the marginal
zone of LT-deficient mouse strains
Paradoxically, VSV infection was lethal in completely
LTb-deficient mice in spite of normal titers of virus-
neutralizing IgM at early time points following infection
(see Fig. 7A). To rule out the possibility that the reduced
number of lymph nodes was responsible for the lethality
of VSV infections in LTb–/– mice, we generated
LTb–/–?B6 BM chimeras. Eight weeks after reconstitu-
tion, these mice have normal numbers of lymph nodes
and mounted normal titers of IgM early after infection
(Fig. 7C), but still succumbed to VSV infections, whilst
control B6?B6 chimeras survived. After VSV infection,
virions are rapidly captured within the MZ via comple-
ment and natural antibodies [29]. T-LTb–/– mice
captured VSV particles as efficiently as C57BL/6 mice,
but B-LTb–/– and TB-LTb–/– mice showed a partial, and
LTb–/– mice a complete impairment of VSV capture in
the MZ (Fig. 7D). This correlated with the VSV titers
detected in the spleen 24 h after infection (Fig. 7E). The
capacity of LTb-deficient mice to fix VSV virions in the
spleen therefore correlated to the integrity of the MZ, as
indicated by the intensity of the MOMA-1 staining (see
Fig. 1A). Similarly, B6?B6 BM chimeras, but not
LTb–/–?B6 BM chimeras, had an intact MZ, to which
VSV particles localized following infection (Fig. 7F). It
has been observed previously that the failure to capture
VSV particles within the MZ results in death of the host,
as a result of systemic virus spread and virus replication
in the brain [30]. This was confirmed in our system by
infecting groups of four C57BL/6, B-LTb–/– and LTb–/–
mice with 2  106 PFU VSV i.v. On day 10, i.e. by the
time that two of the infected LTb–/– mice were taken out
of the experiment due to signs of ascending paralysis,
viral titers in CNS and peripheral organs were
determined for all groups of mice. Live virus was
detected in the brain and spinal cord of only the
moribund, not the symptom-free LTb–/– mice
(104–107 PFU/organ). Interestingly, all peripheral or-
gans of moribund LTb–/– mice were free of virus.
B-LTb–/– mice and B6mice did not contain virus in any of
the organs tested. These results strongly suggest that
death of VSV-infected LTb–/– mice was due to the
cytopathic effect of the virus in the CNS. The inability of
LTb-deficient mice to cope with VSV infections is
therefore likely to be caused by the insufficient capture
of virus within the MZ allowing uncontrolled virus
spread to neuronal tissue.
Reduced capacity to mount CTL responses but
efficient antiviral protection in LT-deficientmouse
strains
We next assessed whether the LTb-deficient mouse
strains showed impaired antiviral CTL responses. For
this purpose, mice were infected with 200 PFU lym-
phocytic choriomeningitis virus (LCMV)-WE i.v. and
CTL expansion and function were assessed at day 8
following infection. Gp33-specific CTL expanded to
comparable numbers in C57BL/6 mice, T-LTb–/– mice
Fig. 6. No detectable difference in the frequency of immature
T cell and B cells between C57BL/6 and LTb–/– mice. (A, upper)
BP-1 and CD24/HSA expression on bonemarrow cells of C57BL/
6 and LTb–/– mice; dot plots were gated on B220+/CD43+ cells.
Frequencies for C57BL/6: Fr.A: 48.2 12%, Fr.B: 24.3 4.8%, Fr.C:
13.3  5.2%, for LTb–/–: Fr.A: 51.4  7.6%, Fr.B: 22.0  4.8%, Fr.C:
11.8 2.6% (n = 3–8). (A, lower). IgM and IgD expression on bone
marrow cells of C57BL/6 and LTb–/– mice; dot plots were gated
on B220+/CD43– cells. Frequencies for C57BL/6: Fr.D: 42.9 
2.2%, Fr.E: 15.3  0.4%, Fr.F: 17.3  2.0%, for LTb–/–: Fr.D: 46.2 
1.6%:, Fr.E: 13.1  3.2%, Fr.F: 25.2  3.8% (n = 3–8,  SD). (B)
Frequencies of IgMhigh/IgDlow transitional and IgMintIgDhigh
mature B cells in spleens of LTb–/– and C57BL/6 mice. Dot plots
were gated on B220+ lymphocytes. (C) CD4 and CD8 expression
of thymocytes of C57BL/6 and LTb–/– mice, gated on live
lymphocytes. Mean percentages are shown for (B) and (C) and
are representative of two to three similar experiments.
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and B-LTb–/– mice, within the spleen, MLN and blood, as
shown by LCMV-gp33-specific tetramer analysis. How-
ever, TB-LTb–/– and particularly LTb–/– showed reduced
numbers of gp33-specific CTL in the spleen (Fig. 8A).
Peptide-specific IFN-c production following in vitro
restimulation for 6 hwas detected in spleens andMLNof
all mice except LTb–/–, with a small reduction of the
frequency of IFN-c-producers in T-LTb–/– mice, a more
substantial reduction in B-LTb–/– and TB-LTb–/– mice,
and an almost complete absence of gp33-specific IFN-c
production in LTb–/– mice (Fig. 8B). Similarly, all LTb-
deficient mouse strains were impaired in their capacity
to specifically lyse 51Cr-labeled target cells (Fig. 8C, left
and middle panels). The impairment of CTL induction
correlated well with the increasing disorganization of
lymphoid structure in the various LTb-deficient mice.
Completely LTb-deficient mice did not mount a
measurable specific CTL response, even following
secondary restimulation in vitro on gp33-pulsed macro-
phages (Fig. 8C, right panel). The observed phenotypes
for CTL activation and expansion were mirrored by
antiviral protection (Fig. 5D): C56BL/6, T-LTb–/– and
B-LTb–/– had completely cleared LCMV from spleen,
liver and kidney by day 8 post infection. TB-LTb–/– but
not LTb–/– mice had eliminated the virus by day 30 post
infection (data not shown), consistent with a previous
Fig. 7. Normal immune responses to VSV in
conditional LTb-knockout mouse strains, ver-
sus impaired immune responses to UV-VSV
and VSV-G. (A) IgM responses to replicating
and non-replicating viral antigens. Antibody
titers of LT-deficient mice and C57BL/6 mice
were determined inmice immunized i.v. with
2  106 PFU VSV-IND (left panel), 109 PFU UV-
VSV (center panel) or 20 lg VSV-G (right
panel) on day 4 following immunization. Bars
represent mean values  SD of n = 3–6 mice.
(B) IgG production of LTb-deficient mouse
strains following immunization with 2 
106 PFU VSV-IND (left panel), 109 PFU UV-
VSV (center panel) or 20 lg VSV-G (right
panel). Data points represent means  SD
of n = 3–6 mice. (C) IgM production of B6?B6
and LTb?B6 bone marrow chimeras on day 4
following infectionwith 2 106 PFUVSV-IND,
n = 3,  SD; (D) Capture of viral antigen in the
spleen 24 h following infection with 5 
108 PFU (original magnification: 120x). Note
that localization and intensity of VSV stain-
ing correlates to the staining of MOMA-1 (see
Fig. 1A). (E) VSV titers in spleens (top panel)
and MLN (bottom panel) 24 h after infection
with 5  108 PFU VSV-IND i.v., horizontal bar
representsmeans. (F) Capture of viral antigen
in the spleen of B6?B6 and LTb?B6 bone
marrow chimeras 24 h after infection with
VSV with 5  108 PFU VSV-IND.
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report showing that LTb–/– mice have the propensity to
become virus carriers [16].
Antiviral CTL can be induced by antigen presentation
in the MZ or T cell zone of the spleen [18]. B-LTb–/– and
LTb–/– mice exhibited fewer LCMV-infected cells at these
sites (Fig. 9, upper panel). When the LCMV-infected
cells were further analyzed, we found similar overall
frequencies of infected cells in spleens (Fig. 9B, red
numbers), but the types of infected cells were distinct
(Fig. 9B): In C57BL/6 mice a significant proportion of
infected cells were DC. Declining numbers of LCMV-
infected DC were detected in B-LTb–/– mice that
exhibited weaker specific CTL responses, and in
LTb–/– mice, where no CTL priming was observed. A
Fig. 8. Reduced capacity to mount productive CTL responses but full antiviral protection in
conditionally LT-deficient mouse strains. (A) Expansion of LCMV-gp33-specific CD8+ T cells in
C57BL/6 mice (open bars) and LTb-deficient mouse strains (filled and hatched bars). Mice were
infectedi.v.with200 PFULCMV-WEandtotalcellnumbersofCD8+tet-gp33+CTLwereassessedfor
blood,spleenandinguinallymphnodes(ILN)onday 8postinfectionbyFACSanalysis.Givenvalues
represent mean  SD (n = 3 per data point). Data shown are from one experiment and are
representative of two separate experiments. (B) Spleens of the indicatedmicewere analyzed for
LCMV-gp33-specific IFN-c-production at day 8 following infection with 200 PFU LCMV-WE i.v.
Mean frequencies of CD8+/IFN-c+ cells are indicated (n = 3 mice). Data shown are from one
experiment andare representativeof two separate experiments. (C, left andmiddlepanel) LCMV-
specificCTLactivityatday 8followinginfectionwith200 PFULCMV-WEi.v.inC57BL/6miceandLT-
deficientmouse strains. Direct ex vivo CTL activity of spleen and lymph node cellswas tested on
51Cr-labeled EL4 cells pulsedwith gp33 (left) or np396 (middle). Data points indicatemean SDof
threemicepergroup.Datashownarefromoneexperimentandarerepresentativeof twoseparate
experiments. (C, right panel) Cytotoxic activity of C57BL/6, TB-LTb–/– and LTb–/– splenocytes on
day 14 after infection, following 5 days of secondary in vitro restimulation on gp33-pulsed
macrophages (seeMaterials andmethods). Datapoints indicatemeanSDof threemicepergroup.
(D)Virus titers in spleen, liver andkidneyonday 8 following infectionwith 200 PFULCMV-WE i.v.
Pooled data of two independent experiments are shown, horizontal bar represents means.
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high number of LCMV-infected DC in the spleen thus
correlated with a strong antiviral CTL response and with
antiviral protection (see Fig. 8). LCMV replicated
inefficiently in splenic DC of LTb–/– mice, likely causing
inefficient CTL priming, uncontrolled virus spread and
CTL exhaustion.
In line with recent findings that DC are critical for the
LCMV-specific CTL response [31], we thus propose that
the LTb-dependent integrity of DC networks is key for
the outcome of the virus-specific CTL response.
Discussion
In this study, we have made use of two well-established
virus models, the non-cytopathic LCMV and the
cytopathic VSV to study the relevance of LTb-dependent
lymphoid structure for initial containment of an
infection and the induction of T and B cell responses.
The failure to contain a cytopathic virus such as VSV
resulted in death of the host, and the failure to rapidly
contain an infection with a non-cytopathic virus such as
LCMV resulted in virus persistence.
The formation of secondary lymphoid organ struc-
ture by LTb-dependent mechanisms is crucial for the
induction of immune responses against viruses [16] and
proteins [21], but it is not clear, at which level LTb
regulates the immune response. We have shown here
that absence of LTb does not interfere with lymphocyte
development or activation on the single-cell level.
Therefore, LTb is likely to determine immune reactivity
mainly via its impact on lymphoid structure. LTb
regulates lymphoid structure at two levels: LTb on LTIC
is critical for the commitment of secondary lymphoid
organ anlage sites [2], LTb expression on B cells, T cells,
LTIC, and potentially other cells such as NK cells defines
lymphoid structure via the induction of chemokines [21,
32, 33]. The generation of conditionally LTb-deficient
mice has allowed us to dissect the relevance of these two
levels of LTb-dependent organization during immune
responses.
The series of C57BL/6, T-, B-, and TB-LTb–/– mice was
found to reflect a gradual decline of LTb-dependent
secondary lymphoid structure. Interestingly, conditional
LTb deficiency caused a more pronounced structural
defect in spleens than in lymph nodes, and the
morphological alterations in B-LTb–/– mice were more
severe than in T-LTb–/– mice, despite similar expression
levels of LTb in spleens and lymph nodes. This was either
caused by the fact that B cells represent the prime source
for LTb during secondary lymphoid organ development
[34], or because the microstructures of lymph nodes
versus spleen rely to a different extent on LTbexpression
[13]. Surprisingly, we did not find a gradual decline of
B cell reactivity in T-, B-, and TB-LTb–/– mice. Instead,
normal titers of neutralizing IgM and IgG were raised
against VSV infection in all strains. In contrast, the non-
replicating antigens UV-VSV and VSV-G both elicited
reduced titers of IgM and IgG in all conditionally LTb-
deficient mice, irrespective of the degree of lymphoid
organ malformation. Reduced formation of IgG has also
been observed in B-LTb–/– and LTb–/– mice when
another non-replicating antigen, SRBC, was used as
an antigen [21]. The stepwise impairment of lymphoid
structure therefore did not necessarily play a role for the
vigor of a B cell response. However, the maturation of
the virus-neutralizing B cell response may have been
affected in LTb-deficient mice, because the GC that were
Fig. 9. Characterization of LCMV-infected DC in spleens on day 2 following infection with LCMV-WE. (A) Primary site of LCMV
infection in the spleen on day 2 following infection of C57BL/6, B-LTb–/– and LTb–/– mice with 2  106 PFU LCMV-WE i.v. LCMV-NP
(VL-4)-positive cells in spleens are indicated in red. Original magnification is 120x. (B) Red numbers indicate the percentages of
splenocytes staining positive for LCMV-NP, and are means of n = 2–5 mice. Dot plots are gated on LCMV-NP (VL-4)-positive
splenocytes, and black numbers represent percentages of CD11c+/CD11b+ cells in this population. Data are from one
representative of n = 2–5 mice.
Tobias Junt et al. Eur. J. Immunol. 2006. 36: 2061–20752070
f 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
induced did not contain FDC-M1+ networks in some
LTb-deficient strains. In addition, lymphoid structure
did not affect the protective capacity of an antiviral CTL
response, but rather the magnitude of this response, as
all conditionally LTb-deficient mouse strains were
protected against LCMV, but the clonal burst was
somewhat weaker in T- and B-LTb–/– mice, and
protection was slower in TB-LTb–/– mice. The deficiency
of NK cells in LTb–/– mice [22] may additionally
negatively affect early VSV control [35, 36], but there
is evidence that the absence of NK cells does not
significantly delay LCMV clearance [37].
The role of LTb in lymph node anlage commitment
became apparent if TB-LTb–/– mice were compared with
LTb–/– mice. Commitment of anlage sites was governed
by expression of LTb on non-T/non-B cells, because TB-
LTb–/– mice had all lymph nodes with normal cellularity.
Similarly, these cells are responsible for the induction of
a functional MZ, and the accumulation of MOMA-1+
macrophages in the marginal sinus in TB-LTb–/– mice.
Bone marrow reconstitutions of LTb–/–?B6 established
that it was not the reduced number of lymph nodes, but
the complete absence of a functional MZ that caused
death of LTb–/– mice following VSV infection.
An intact MZ also contributes to the initial contain-
ment of LCMV infection, preventing hematogenic spread
and excessive replication of the virus in the periphery
[30, 38]. Therefore, the reduced CTL priming efficiency
in B-LTb–/–, TB-LTb–/– and LTb–/– could partly be caused
by a defective MZ. CTL priming efficiency additionally
correlated with a high number of LCMV-infected DC, in
line with the key role of DC in antiviral protection
against LCMV [31].
Overall,we conclude that the expressionof LTbbyTor
B lymphocytes creates specialized environments for the
detection of low quantities of antigen (e.g. UV-VSV, VSV-
G, andSRBC)by rare precursor cells.However, theseLTb-
dependent lymphoid microenvironments seemed of
minor importance if large quantities of antigen (e.g.
replicating virus) efficiently reached secondary lym-
phoid organs. Expression of LTb on non-T, non-B cells
(i.e. NK cells, macrophages or LTIC) was responsible for
the induction of macrophage networks at the MZ and for
the generation of DC networks. If these organized sites of
antigen presentation were missing, antigen could not be
efficiently retained and presented within secondary
lymphoid organs. Consequently, virus spread systemi-
cally and no efficient immune response was induced.
This eventually resulted in CTL exhaustion following
LCMV infection, or death of the host following VSV
infection. LTb expression thus influences immunity at
two distinct levels: (i) by increasing the probability of
cell-cell interactions within secondary lymphoid organs,
and (ii) by supporting antigen sampling of APC within
secondary lymphoid organs.
The fact that even minor alterations of secondary
lymphoid organ microstructure impaired immune
responses against non-replicating antigens underscores
the importance of lymphoid microstructure for vaccina-
tions. Vaccinations are most frequently performed with
attenuated or inactivated pathogens, with proteins or
with low amounts of other non-replicating antigens. In
humans, there is one particular and crucial situation
where a defective lymphoid structure can limit the
efficacy of vaccinations. Newborns lack clearly orga-
nized lymphoid structures [39]; in particular, they
exhibit an immature MZ [40]. This may explain why
newborns fail to induce potent immune responses
against many vaccines [41].
Materials and methods
Mice
LTb-floxed mice [21] were crossed to CD19Cre knock-in mice
[42] or to the lckCre transgenic mice [43] for subsequent
generation of B-LTb–/– and T-LTb–/– mice, respectively. The
lckCre and CD19Cre constructs ablated expression of LTb on
T and B cells, respectively, to more than 98% [13]. T-LTb–/–
mice and B-LTb–/– mice were intercrossed to obtain TB-LTb–/–
mice. LTb–/– mice were bred and genotyped as described [8].
The following PCR conditions were chosen for typing of the
LTb-flox allele: Pri3ltb: 50-GGGAGGGGATTGTGTCCG AG-30;
Pri5ltb: 50-TCT TCC CTA AAC TCC AAT CAG C-30; KO46: 50-
GGG GTG ACC TAG ATA GTG CC-30; 35 cycles of 94C, 45 s;
61C, 45 s; 72C, 60 s (products for WT: 0.2 kb, LTb-flox:
0.25 kb, deleted 0.4 kb). For typing of the CD19Cre allele:
CD19.8: 50-AAT GTT GTG CTG CCA TGC CTC-30; CD19.9: 50-
GTC TGA AGC ATT CCA CCG GAA-30; lck2: 50-AAT GTT GCT
GGA TAG TTT TTA CTG C-30; 35 cycles of 94C, 60 s; 60C,
60 s 72C, 120 s (products for WT: 500 bp, for CD19Cre:
400 bp). For typing of the lckCre allele: lck1: 50-CCT TGG TGG
AGG AGGGTGGAATGA A-30; lck2: 50-AAT GTT GCT GGATAG
TTT TTA CTG C-30; lck3: 50-TAG AGC CCT GTT CTG GAA GTT
ACA A-30; 35 cycles of 94C, 60 s; 60C, 60 s 72C, 120 s
(products for WT: 0.35 kb, for lckCre 0.6 kb). All mice were
backcrossed to C57BL/6 for at least nine times. BM chimeras
were generated by lethal irradiation (9.5 Gy from a 57Co
source) of C57BL/6mice and i.v. injection of BM cells from sex-
matched donors. BM chimeras were given Borgal (Hoechst
Roussel Vet, Lyssach, Switzerland) in the drinking water
(1 mg/mL Sulfadoxin, 0.2 mg/mL Trimethoprim) during the
first 2 weeks after reconstitution and left for 8 weeks before
use in experiments. Animals were kept at the Biologische
Zentrallabor, University of Zrich, Switzerland. All animal
experiments were performed in accordance with the Swiss
Federal legislation on animal protection.
Viruses and peptides
LCMV, WE strain, originally obtained from Dr. F. Lehmann-
Grube (Heinrich-Pette-Institut, Hamburg, Germany), was
propagated on L929 cells at a low MOI and was quantified
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as previously described [44]. VSV, Indiana strain (VSV-IND,
Mudd-Summers isolate), was originally obtained from Prof. D.
Kolakofsky (University of Geneva, Switzerland). VSV-IND was
propagated on baby hamster kidney 21 (BHK-21) cells and
quantified by plaque assay on Vero cells. For some experi-
ments, UV-inactivated VSV-IND was obtained using UV
irradiation (7UV 15 W, Philips) for 3 min using a thin layer
of solution in a plastic dish with periodical mixing. The LCMV-
GP peptide KAVYNFATC (gp33) and the LCMV-NP peptide
FQPGNGQFI (np396) were purchased from Neosystem
(Strasbourg, France).
LCMV-specific cytotoxic T cell response
Specific cytotoxicity was determined ex vivo in a standard 51Cr-
release assay as described [45]. Briefly, cell suspensions were
prepared from spleens or lymph nodes of immunized mice at
the indicated time point after priming. For LCMV-specific CTL
assays, EL-4 cells were labeledwith gp33 (10–6 M) and 250 lCi
51Cr for 1.5 h at 37C. Target cells (104/well) were incubated
for 4 h in 96-well round-bottom plates with threefold serial
dilutions of spleen or lymph node effector cells, starting at an
effector to target (E:T) ratio of 90:1. EL-4 cells without peptide
served as controls. The supernatants of the cytotoxicity assay
cultures were counted in a Cobra II Gamma Counter (Canberra
Packard). Percentage of specific lysis was calculated as
(experimental release – spontaneous release)/(total release
– spontaneous release) 100. Spontaneous release was always
below 20%. In some experiments, the 51Cr-release assay
followed a 5-day restimulation period of splenocytes on
irradiated thioglycollate-elicited peritoneal macrophages
pulsed with gp33.
VSV neutralization assay
Neutralizing antibody titers of sera were determined as
described [46]. Sera were prediluted 40-fold in supplemented
MEM and heat-inactivated for 30 min at 56C. Serial 2-fold
dilutions were mixed with equal volumes of virus diluted to
contain 500 PFU/mL. Themixture was incubated for 90 min at
37C in an atmosphere containing 5% CO2. The serum-virus
mixture (100 lL) was transferred onto Vero cell monolayers in
96-well plates and incubated for 1 h at 37C. The monolayers
were then overlaid with 100 lL DMEM containing 1% methyl
cellulose. After incubation for 24 h at 37C the overlay was
removed and the monolayer was fixed and stained with 0.5%
crystal violet. The highest dilution of the serum that reduced
the number of plaques by 50% was taken as the neutralizing
titer. IgG titers were determined by treating undiluted serum
with an equal volume of 0.1 M 2-ME in saline.
Construction of tetrameric class I-peptide complexes
and flow cytometry
All fluorochrome-labeled antibodies for cytofluorimetric
analyses and for fluorescence microscopy were purchased
from PharMingen BD unless indicated otherwise. MHC class I
(H-2Db) tetramers complexed with gp33 were produced as
previously described [47] with modifications [48]. At the
indicated time points after immunization, animals were bled
and single-cell suspensions were prepared from spleen and
lymph nodes. Aliquots of 5  105 cells or three drops of blood
were stained using 50 lL of a solution containing tetrameric
class I-peptide complexes at 37C for 10 min followed by
staining with anti-CD8-FITC (BD PharMingen) at 4C for
20 min. Erythrocytes in blood samples were lysed with FACS
lysis solution (Becton Dickinson) and the cells were analyzed
on a FACScalibur flow cytometer (Becton Dickinson) after
gating on viable leukocytes, using the Cellquest software. For
the determination of absolute cell counts, the number of total
viable leukocytes was assessed in an improved Neubauer
chamber. The number of total viable leukocytes in blood was
automatically determined in an Advia counter (Bayer,
Germany) in the Central Hematology Laboratory of the
University Hospital Zrich.
Intracellular cytokine staining
Spleens were removed at the indicated time points after
infection with LCMV. Single-cell preparations of 1  106
splenocytes were incubated for 5 h at 37C in 96-well round-
bottom plates in 200 lL culture medium containing 25 U/mL
IL-2 and 5 lg/mL Brefeldin A (Sigma). Splenocytes were
stimulated with PMA (50 ng/mL) and ionomycin (500 ng/
mL) as a positive control or left untreated as a negative control.
For analysis of peptide-specific responses, 106 splenocytes were
stimulated by adding 106 M gp33. After stimulation, spleno-
cytes were surface stained with anti-CD8-PE (53–5.8, Phar-
Mingen) in FACS-buffer (PBS + 2% FCS + 20 mM EDTA +
0.03% NaN3) for 1 h at 4
C. Splenocytes were washed once
with FACS-buffer, fixed with 100 lL 4% paraformaldehyde in
PBS for 5 min at 4C, and permeabilized with 2 mL of
permeabilization buffer (FACS-buffer + 0.1% saponin) for
5 min at 4C. Cells were then stained intracellularly with anti-
IFN-c-FITC (AN18, [49]) in permeabilization buffer for 30 min
at 4C. Cells were washed twice with permeabilization buffer,
and the percentage of IFN-c-producing cells was determined
after gating on CD8+ cells using a FACScalibur flow cytometer.
Data analysis was performed with the Cellquest software.
Homing experiments
Thy1.2+ T cells and B220+ B cells were purified by magnetic-
bead assisted cell sorting (MACS, Miltenyi Biotech, Bergisch
Gladbach, Germany) from spleens of C57BL/6 mice or LTb–/–
mice and labeled with CFSE for 10 min at 37C as described
[50]. Cells (3  106) were adoptively transferred i.v. to naive
C57BL/6 mice. Six hours post transfer, spleens were taken and
analyzed by fluorescence microscopy.
Immunohistochemistry and fluorescence microscopy
For immunohistochemistry, 5-lm cryostat sections were fixed
in acetone for 10 min and subsequently incubated with anti-
mouse B220 (RA3–3A1/6.1, ATCC, Rockville, MD), anti-
mouse CD4 (GK1.5), anti-mouse CD8 (53–6.7, BD PharMin-
gen), anti-mouse 4C11 (FDCM1, BD Biosciences), anti-mouse
MadCAM (MECA367, PharMingen) or anti-mouse MOMA-1
[51]. Goat anti-rat Ig (Caltag) in 5% normal mouse serum was
used as a secondary reagent, alkaline phosphatase-labeled,
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species-specific donkey anti-goat (Jackson ImmunoResearch)
in 5% normal mouse serum was used as tertiary reagents. The
substrate for the red color reaction was naphtol AS-BI
phosphate/New Fuchsin. Endogenous alkaline phosphatase
was blocked with levamisole. Sections were counterstained
with hemalum. Staining for VSV antigen was performed as
described previously [52]. For fluorescence microscopy,
acetone-fixed 5-lm cryostat sections were incubated for
10 min with 10 lg/mL 2.4G2 antibody to block Fc receptors,
and washed with PBS. Sections were then incubated for
60 min with 10 lg/mL of the biotinylated or FITC-labeled
antibodies in a wet chamber, washed with PBS, and incubated
with streptavidin-TRITC for 30 min in a wet chamber. Sections
were washed in PBS, counterstained with DAPI (Chemicon
International, Temecula, CA), mounted with fluorescence
mounting solution (DAKO, Carpinteria, CA) and analyzed by
fluorescence microscopy using a BX61 fluorescence micro-
scope (Olympus, Volketswil, Switzerland). All reagents for
fluorescent microscopy were diluted in PBS 1%FCS.
In vitro restimulation of T and B cells and ELISA
CD4+ and CD8+ T cells were isolated from splenocyte
suspensions of C57BL/6 mice or LTb–/– mice by MACS
(Miltenyi Biotech, Bergisch Gladbach, Germany). They were
cultivated in RPMI 10% FCS for 3 or 5 days on plastic plates
coated with 10 lg/mL anti-CD3 (2C11) in the presence of
10 mg/mL anti-CD28 (37.51) and 50 U/mL IL-2. Untouched
B cells were isolated from splenocyte suspensions of C57BL/6
mice and LTb–/– mice by MACS using anti-CD43 magnetic
beads and an AutoMACS separator. They were cultivated in
RPMI 10% FCS for 3 days in the presence of 15 lg/mL anti-
CD40 (FGK45.5, a kind gift from A. Rolink) and 1000 U/mL
recombinant mouse IL-4 or 500 U/mL recombinant mouse
IFN-c, respectively. In some cases, anti-CD40 was replaced by
10 lg/mL LPS. In some experiments, cells were labeled with
CFSE as described [50].
Real-time PCR
RNA was extracted using TRIZOL according to manufacturer's
instructions (Invitrogen). Extracted RNA (2 lg) was subjected
to DNase digest and subsequent reverse transcription using the
Superscript kit (Invitrogen). SYBRgreen-based (Applied Bio-
systems, Foster City, CA) real-time PCR was carried out in an
ABIPrism 7700 Sequence Detector using the SDS 1.9 software
and the following primers: LTb.up: 50- CGT CTA TTA CCT CTA
CTG CC –30; LTb.do: 50- CGT GTA CCA TAA CGA CCC GT –30;
LTa.up: 50- CCC TCAGAAGCACTT GAC C –30; LTa.do: 50- CAG
AGA AAA CCA CCT GGG AG –30; TNF.up: 50- CAT CTT CTC
AAA ATT CGA GTG ACA A –30; TNF.do: 50- TGG GAG TAG ACA
AGG TAC AAC CC –30; LIGHT.up: 50- ATG GAG AGT GTG GTA
CAG CCT TC –30; LIGHT.do: 50- GAC CAT GAA AGC TCC GAA
ATA GG –30; GAPDH.up: 50- CCA CCC CAG CAA GGA CAC T
–30; GAPDH.do: 50- GAA ATTGTG AGGGAGATGCTC AGT –30.
Cell populations were MACS-sorted from spleens of naive B6
mice as follows: B cells, CD43 depletion; T cells, CD4 or CD8
enrichment; NK cells, DX5 enrichment, DC, CD11c enrich-
ment. Macrophages were isolated from peritoneal lavages by
B220 and DX5 depletion and subsequent CD11b enrichment.
Purities ranged between 85% (NK cells) to>92% (all other cell
types). Similar LTb expression data were obtained with FACS-
sorted cells (FACSAria, BD Biosciences). Relative mRNA
expression was calculated as follows: Dct values between
the expression curves of LTb and GAPDH were determined for
all samples. The mean Dct value for B6 samples was subtracted
from all other samples to determine expression levels relative
to B6. DDct values were then converted to percent by taking
into account the PCR amplification factor 2x, and SD were
calculated within each experimental group.
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